Hepatoprotective effects of berberine on liver fibrosis via activation of AMP-activated protein kinase

Life Sciences

Volumn 98, Issue 1, 2014, Pages 24-30

  Li, Jing ^a   Pan, Yue ^a   Kan, Mujie ^a   Xiao, Xuanang ^a   Wang, Yunjing ^a   Guan, Fengying ^a   Zhang, Xuewen ^b   Chen, Li ^a  

^a JILIN UNIVERSITY   (China)

^b CHINA JAPAN UNION HOSPITAL OF JILIN UNIVERSITY   (China)

Author keywords

Akt; AMPK; Berberine; Liver fibrosis; ROS

Indexed keywords

AKT; AMPK; BERBERINE; LIVER FIBROSIS; ROS;

AMP-ACTIVATED PROTEIN KINASES; ANIMALS; BERBERINE; BLOTTING, WESTERN; BODY WEIGHT; CELL PROLIFERATION; CELL SURVIVAL; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME ACTIVATION; ENZYME ACTIVATORS; GENE EXPRESSION REGULATION; HEPATIC STELLATE CELLS; LIVER; LIVER CIRRHOSIS; MALE; MICE; MICE, INBRED ICR; RATS;

EID: 84894454902     PISSN: 00243205     EISSN: 18790631     Source Type: Journal    
DOI: 10.1016/j.lfs.2013.12.211     Document Type: Article

References (37)

1. M. Allman, L. Gaskin, and C.A. Rivera CCl4-induced hepatic injury in mice fed a Western diet is associated with blunted healing J Gastroenterol Hepatol 25 2010 635 643
2. R. Bataller NADPH oxidase signal transduces angiotensin II in hepatic stellate cells and is critical in hepatic fibrosis J Clin Invest 112 2003 1383 1394
3. A. Bosserhoff, and C. Hellerbrand Obesity and fatty liver are 'grease' for the machinery of hepatic fibrosis Dig Dis 29 2011 377 383
4. I. Carmona-Cuenca, C. Roncero, P. Sancho, L. Caja, N. Fausto, M. Fernandez, and I. Fabregat Upregulation of the NADPH oxidase NOX4 by TGF-beta in hepatocytes is required for its pro-apoptotic activity J Hepatol 49 2008 965 976
5. G. Ceolotto, A. Gallo, I. Papparella, L. Franco, E. Murphy, E. Iori, E. Pagnin, G.P. Fadini, M. Albiero, A. Semplicini, and A. Avogaro Rosiglitazone reduces glucose-induced oxidative stress mediated by NAD(P)H oxidase via AMPK-dependent mechanism Arterioscler Thromb Vasc Biol 27 2007 2627 2633
6. E.C. Chan, F. Jiang, H.M. Peshavariya, and G.J. Dusting Regulation of cell proliferation by NADPH oxidase-mediated signaling: potential roles in tissue repair, regenerative medicine and tissue engineering Pharmacol Ther 122 2009 97 108
7. F.J. Cubero, R. Urtasun, and N. Nieto Alcohol and liver fibrosis Semin Liver Dis 29 2009 211 221
8. A. Da Silva Morais, J. Abarca-Quinones, B. Guigas, B. Viollet, P. Starkel, Y. Horsmans, and I.A. Leclercq Development of hepatic fibrosis occurs normally in AMPK-deficient mice Clin Sci (Lond) 118 2010 411 420
9. L. Dai, H. Ji, X.W. Kong, and Y.H. Zhang Antifibrotic effects of ZK14, a novel nitric oxide-donating biphenyldicarboxylate derivative, on rat HSC-T6 cells and CCl4-induced hepatic fibrosis Acta Pharmacol Sin 31 2010 27 34
10. S. De Minicis, and D.A. Brenner NOX in liver fibrosis Arch Biochem Biophys 462 2007 266 272
11. Z.Y. Deng, J. Li, Y. Jin, X.L. Chen, and X.W. Lu Effect of oxymatrine on the p38 mitogen-activated protein kinases signalling pathway in rats with CCl4 induced hepatic fibrosis Chin Med J 122 2009 1449 1454
12. R. Domitrovic, H. Jakovac, and G. Blagojevic Hepatoprotective activity of berberine is mediated by inhibition of TNF-alpha, COX-2, and iNOS expression in CCl(4)-intoxicated mice Toxicology 280 2011 33 43
13. A.A. Eid, B.M. Ford, K. Block, B.S. Kasinath, Y. Gorin, G. Ghosh-Choudhury, J.L. Barnes, and H.E. Abboud AMP-activated protein kinase (AMPK) negatively regulates Nox4-dependent activation of p53 and epithelial cell apoptosis in diabetes J Biol Chem 285 2010 37503 37512
14. P. Greenwel, J. Rubin, M. Schwartz, E.L. Hertzberg, and M. Rojkind Liver fat-storing cell clones obtained from a CCl4-cirrhotic rat are heterogeneous with regard to proliferation, expression of extracellular matrix components, interleukin-6, and connexin 43 Lab Invest 69 1993 210 216
15. D.G. Hardie, F.A. Ross, and S.A. Hawley AMPK: a nutrient and energy sensor that maintains energy homeostasis Nat Rev Mol Cell Biol 13 2012 251 262
16. J. Herrmann, A.M. Gressner, and R. Weiskirchen Immortal hepatic stellate cell lines: useful tools to study hepatic stellate cell biology and function? J Cell Mol Med 11 2007 704 722
17. Q. Jiang, P. Liu, X. Wu, W. Liu, X. Shen, T. Lan, S. Xu, J. Peng, X. Xie, and H. Huang Berberine attenuates lipopolysaccharide-induced extracelluar matrix accumulation and inflammation in rat mesangial cells: involvement of NF-kappaB signaling pathway Mol Cell Endocrinol 331 2011 34 40
18. S. Kanzler, A.W. Lohse, A. Keil, J. Henninger, H.P. Dienes, P. Schirmacher, S. Rose-John, K.H. zum Buschenfelde, and M. Blessing TGF-beta1 in liver fibrosis: an inducible transgenic mouse model to study liver fibrogenesis Am J Physiol 276 1999 G1059 G1068
19. T.D. King, L. Song, and R.S. Jope AMP-activated protein kinase (AMPK) activating agents cause dephosphorylation of Akt and glycogen synthase kinase-3 Biochem Pharmacol 71 2006 1637 1647
20. X. Kong, N. Horiguchi, M. Mori, and B. Gao Cytokines and STATs in liver fibrosis Front Physiol 3 2012 69
21. R. Lage, C. Dieguez, A. Vidal-Puig, and M. Lopez AMPK: a metabolic gauge regulating whole-body energy homeostasis Trends Mol Med 14 2008 539 549
22. G.M. Leclerc, G.J. Leclerc, G. Fu, and J.C. Barredo AMPK-induced activation of Akt by AICAR is mediated by IGF-1R dependent and independent mechanisms in acute lymphoblastic leukemia J Mol Signal 5 2010 15
23. J. Li, B. Cao, X. Liu, X. Fu, Z. Xiong, L. Chen, O. Sartor, Y. Dong, and H. Zhang Berberine suppresses androgen receptor signaling in prostate cancer Mol Cancer Ther 10 2011 1346 1356
24. Y. Lu, N. Azad, L. Wang, A.K. Iyer, V. Castranova, B.H. Jiang, and Y. Rojanasakul Phosphatidylinositol-3-kinase/akt regulates bleomycin-induced fibroblast proliferation and collagen production Am J Respir Cell Mol Biol 42 2010 432 441
25. A. Probst, T. Dang, M. Bochud, M. Egger, F. Negro, and P.Y. Bochud Role of hepatitis C virus genotype 3 in liver fibrosis progression - a systematic review and meta-analysis J Viral Hepat 18 2011 745 759
26. V. Sanchez-Valle, N.C. Chavez-Tapia, M. Uribe, and N. Mendez-Sanchez Role of oxidative stress and molecular changes in liver fibrosis: a review Curr Med Chem 19 2012 4850 4860
27. S.M. Schultze, B.A. Hemmings, M. Niessen, and O. Tschopp PI3K/AKT, MAPK and AMPK signalling: protein kinases in glucose homeostasis Expert Rev Mol Med 14 2012 e1
28. L. Serrander, L. Cartier, K. Bedard, B. Banfi, B. Lardy, O. Plastre, A. Sienkiewicz, L. Forro, W. Schlegel, and K.H. Krause NOX4 activity is determined by mRNA levels and reveals a unique pattern of ROS generation Biochem J 406 2007 105 114
29. X. Sun, X. Zhang, H. Hu, Y. Lu, J. Chen, K. Yasuda, and H. Wang Berberine inhibits hepatic stellate cell proliferation and prevents experimental liver fibrosis Biol Pharm Bull 32 2009 1533 1537
30. F. Tacke, and R. Weiskirchen Update on hepatic stellate cells: pathogenic role in liver fibrosis and novel isolation techniques Expert Rev Gastroenterol Hepatol 6 2012 67 80
31. S. Wang, M. Zhang, B. Liang, J. Xu, Z. Xie, C. Liu, B. Viollet, D. Yan, and M.H. Zou AMPKalpha2 deletion causes aberrant expression and activation of NAD(P)H oxidase and consequent endothelial dysfunction in vivo: role of 26S proteasomes Circ Res 106 2010 1117 1128
32. K. Wu, Q. Yang, Y. Mu, L. Zhou, Y. Liu, Q. Zhou, and B. He Berberine inhibits the proliferation of colon cancer cells by inactivating Wnt/beta-catenin signaling Int J Oncol 41 2012 292 298
33. R. Xu, Z. Zhang, and F.S. Wang Liver fibrosis: mechanisms of immune-mediated liver injury Cell Mol Immunol 9 2011 296 301
34. L.F. Yu, B.Y. Qiu, F.J. Nan, and J. Li AMPK activators as novel therapeutics for type 2 diabetes Curr Top Med Chem 10 2010 397 410
35. B.B. Zhang, G. Zhou, and C. Li AMPK: an emerging drug target for diabetes and the metabolic syndrome Cell Metab 9 2009 407 416
36. H. Zhang, J. Wei, R. Xue, J.D. Wu, W. Zhao, Z.Z. Wang, S.K. Wang, Z.X. Zhou, D.Q. Song, and Y.M. Wang et al. Berberine lowers blood glucose in type 2 diabetes mellitus patients through increasing insulin receptor expression Metabolism 59 2010 285 292
37. H.W. Zimmermann, and F. Tacke Modification of chemokine pathways and immune cell infiltration as a novel therapeutic approach in liver inflammation and fibrosis Inflamm Allergy Drug Targets 10 2011 509 536